Page 1
Page 1
Started By
Message

Better contribution for Roth IRA. Money in Eli Lilly or NVDA?

Posted on 2/12/24 at 8:01 am
Posted by Granola
Member since Jan 2024
447 posts
Posted on 2/12/24 at 8:01 am
Where would go between these to choices?
Posted by OceanMan
Member since Mar 2010
20009 posts
Posted on 2/12/24 at 8:06 am to
Index
Posted by DarthRebel
Tier Five is Alive
Member since Feb 2013
21237 posts
Posted on 2/12/24 at 10:45 am to
Why not both

You know the growth with NVDA is amazing and AI speculation is the new hotness and no signs of slowing down yet. It has really gone up though, who knows how much more?

LLY has Mounjara already for diabetes, but just had Zepbound approved by FDA last year for obese patients. Zepbound should be hitting in 2024 sales. Those two alone could exceed $25 billion in sales over time.

They have had similar growth over the past year. LLY seems safer to me, but I have both.
Posted by Granola
Member since Jan 2024
447 posts
Posted on 2/12/24 at 11:19 am to
I currently have both positions in my Roth IRA. Just curious as to which would be better for this years contribution. I love both stocks. I understand what you said, Eli Lilly might be a bit safer.
first pageprev pagePage 1 of 1Next pagelast page
refresh

Back to top
logoFollow TigerDroppings for LSU Football News
Follow us on Twitter, Facebook and Instagram to get the latest updates on LSU Football and Recruiting.

FacebookTwitterInstagram